| Literature DB >> 27653266 |
Lillian Atsumi Simabuguro Chinem1, Beatriz de Souza Vilella2, Cláudia Lúcia de Pinho Maurício3, Lucia Viviana Canevaro3, Luiz Fernando Deluiz4, Oswaldo de Vasconcellos Vilella2.
Abstract
OBJECTIVE: The aim of this study was to compare the equivalent and effective doses of different digital radiographic methods (panoramic, lateral cephalometric and periapical) with cone-beam computed tomography (CBCT).Entities:
Mesh:
Year: 2016 PMID: 27653266 PMCID: PMC5029318 DOI: 10.1590/2177-6709.21.4.066-072.oar
Source DB: PubMed Journal: Dental Press J Orthod ISSN: 2176-9451
Location of thermoluminescent dosimeters in Alderson Rando phantom.
| Organ/Tissue | Location | TLDs |
| Bone marrow | Anterior calvarium | 1 |
| Posterior calvarium | 2 | |
| Left calvarium | 3 | |
| Center cervical spine | 12 | |
| Right/left ramus | 10, 11 | |
| Right/left mandibular body | 14, 15 | |
| Brain | Mid brain | 7 |
| Pituitary fossa | 4 | |
| Eyes | Right/left orbit | 5, 6 |
| Right/left lens of eye | 21-24* | |
| Salivary glands | Right/left parotid | 8, 9 |
| Right/left submandibular gland | 16, 17 | |
| Sublingual gland | 13 | |
| Thyroid | Thyroid surface | 19* |
| Midline thyroid | 18 | |
| Skin | Right cheek | 25, 26* |
| Left back of neck | 27, 28* | |
| Esophagus | Pharyngeal-esophageal space | 20 |
*Dosimeters positioned on the surface of the phantom. TLDs: thermoluminescent dosimeters.
Parameters adopted.
| FOV* | kV** | mA*** | Exposure time (s) | |
| Heliodent plus | Periapical | 70 | 7 | 0.25 - 0.4 |
| Orthophos XG 5 | Panoramic | 69 | 15 | 14.1 |
| Orthophos XG 5 | Cephalometric | 80 | 14 | 9.4 |
| i-CAT | 22 cm | 120 | 3 - 7 | 40 |
*Field of view. **Kilovoltage. *** Milliamperes.
Estimated percentage of tissue irradiated and dosimeters used to calculate mean absorbed dosage.
| Organ/Tissue | Fraction irradiated (%) | TLD |
| Bone marrow | 16.5 | |
| Mandible | 1.3 | 10, 11, 14, 15 |
| Calvarium | 11.8 | 1-3 |
| Cervical spine | 3.4 | 12 |
| Thyroid | 100 | 18, 19 |
| Esophagus | 10 | 20 |
| Skin | 5 | 21-28 |
| Bone surface | 16.5 | |
| Mandible | 1.3 | 10, 11, 14, 15 |
| Calvarium | 11.8 | 1-3 |
| Cervical spine | 3.4 | 12 |
| Salivary glands | 100 | |
| Parotid | 100 | 8, 9 |
| Submandibular | 100 | 16, 17 |
| Sublingual | 100 | 13 |
| Brain* | 100 | 4, 7 |
| Remainder | ||
| Brain** | 100 | 4, 7 |
| Lymphatic nodes* | 5 | 1-12 |
| Muscles*,** | 5 | 1-12 |
| Extrathoracic airway* | 100 | 5, 6, 8-12 |
| Oral mucosa* | 100 | 8-11, 13 |
*ICRP 2007 recommendations , **ICRP 1990 recommendations. TLD: thermoluminescent dosimeter.
Tissue weighting factors - ICRP 1990 and 2007 recommendations.
| Organ/Tissue | WT 1990 | WT2007 |
| Bone marrow | 0.12 | 0.12 |
| Breast | 0.05 | 0.12 |
| Colon | 0.12 | 0.12 |
| Lung | 0.12 | 0.12 |
| Stomach | 0.12 | 0.12 |
| Bladder | 0.05 | 0.04 |
| Esophagus | 0.05 | 0.05 |
| Gonads | 0.20 | 0.08 |
| Liver | 0.05 | 0.04 |
| Thyroid | 0.05 | 0.05 |
| Bone surface | 0.01 | 0.01 |
| Brain | Remainder | 0.01 |
| Salivary glands | - | 0.01 |
| Skin | 0.01 | 0.01 |
| Remainder | 0.05* | 0.10** |
*Adrenals, brain, upper large intestine, small intestine, kidney, muscle, pancreas, spleen, thymus and uterus. **Adrenals, extrathoracic region, gall bladder, heart, kidneys, lymphatic nodes, muscle, oral mucosa, pancreas, prostate, small intestine, spleen, thymus and uterus.
Mean of equivalent doses (µSv) of each organ or tissue, effective doses (µSv) and percentage of equivalent and effective doses of all devices compared to CBCT.
| Organ/Tissue | Cephalometric | Panoramic | Periapical | CBCT | Radiographic set | Radiographic set/CBCT (%) |
| Thyroid | 5.1 | 34.5 | 1.1 | 388.5 | 40.7 | 10.5 |
| Bone marrow | 3.3 | 21.4 | 66.3 | 279.6 | 91 | 32.5 |
| Esophagus | 0.7 | 3.4 | 10 | 89.7 | 14.1 | 15.7 |
| Skin | 1 | 36.2 | 0.7 | 0.2 | 37.9 | 18950.0 |
| Bone surface | 12.1 | 87.7 | 3268.4 | 556.4 | 3368.2 | 605.4 |
| Salivary glands | 26.4 | 359.1 | 932.2 | 1908.2 | 1317.7 | 69.1 |
| Brain** | 14 | 33.9 | 139.7 | 2985.3 | 187.6 | 6.3 |
| Remainder | ||||||
| Brain* | 14 | 33.9 | 139.7 | 2985.3 | 187.6 | 6.3 |
| Lymphatic nodes** | 1.3 | 18 | 46.6 | 95.4 | 65.9 | 69.1 |
| Extrathoracic airways** | 26.4 | 359.1 | 932.2 | 1908.2 | 1317.7 | 69.1 |
| Muscles*,** | 1 | 5.6 | 70.4 | 62.3 | 77 | 123.6 |
| Oral mucosa** | 23.2 | 316 | 839.7 | 1813.1 | 1178.9 | 65.0 |
| Effective dosage ICRP 90 | 1.2 | 6.7 | 16.5 | 139.2 | 24.4 | 17.5 |
| Effective dosage ICRP 07 | 2.5 | 27.1 | 69.1 | 208.9 | 98.7 | 47.2 |
*ICRP 1990; **ICRP 2007.